{"entity":{"type":"insider","cik":"0001643756","url":"/insider/0001643756","json_url":"/insider/0001643756.json","name":"Aunins John G.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":21,"n_filings":18,"first":"2016-03-29","last":"2018-12-19","span_basis":"filed_date"},"name_variants":[{"name":"Aunins John G.","source":"filing","n_filings":18,"first_seen":"2016-03-29","last_seen":"2018-12-19"}],"transactions":[{"id":6817252,"accession":"0000899243-18-031411","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-031411","line_url":"/filing/0000899243-18-031411#line-1","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001643756","owner_name":"Aunins John G.","owner_display_name":"Aunins John G.","owner_url":"/insider/0001643756","role":"Officer (Chief Technology Officer & EVP)","role_mark":"O","role_mark_label":"Officer (Chief Technology Officer & EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer & EVP","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14282.0,"shares_display":"14,282","price_per_share":6.3936,"price_display":"6.39","price_state":"stated","total_value":91313.3952,"total_display":"91,313.40","total_whole":"91,313","shares_owned_after":75250.0,"shares_owned_after_display":"75,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-17","filed_date":"2018-12-19","scope":"insider"},{"id":6491929,"accession":"0000899243-18-029310","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-029310","line_url":"/filing/0000899243-18-029310#line-1","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001643756","owner_name":"Aunins John G.","owner_display_name":"Aunins John G.","owner_url":"/insider/0001643756","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14279.0,"shares_display":"14,279","price_per_share":8.2577,"price_display":"8.26","price_state":"stated","total_value":117911.6983,"total_display":"117,911.70","total_whole":"117,912","shares_owned_after":89532.0,"shares_owned_after_display":"89,532","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-15","filed_date":"2018-11-19","scope":"insider"},{"id":6178690,"accession":"0000899243-18-026790","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-026790","line_url":"/filing/0000899243-18-026790#line-1","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001643756","owner_name":"Aunins John G.","owner_display_name":"Aunins John G.","owner_url":"/insider/0001643756","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14279.0,"shares_display":"14,279","price_per_share":5.9388,"price_display":"5.94","price_state":"stated","total_value":84800.1252,"total_display":"84,800.13","total_whole":"84,800","shares_owned_after":103811.0,"shares_owned_after_display":"103,811","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-15","filed_date":"2018-10-16","scope":"insider"},{"id":6849669,"accession":"0000899243-18-024819","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-18-024819","line_url":"/filing/0000899243-18-024819#line-3","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001643756","owner_name":"Aunins John G.","owner_display_name":"Aunins John G.","owner_url":"/insider/0001643756","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14279.0,"shares_display":"14,279","price_per_share":7.2747,"price_display":"7.27","price_state":"stated","total_value":103875.4413,"total_display":"103,875.44","total_whole":"103,875","shares_owned_after":118090.0,"shares_owned_after_display":"118,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-17","filed_date":"2018-09-19","scope":"insider"},{"id":6849666,"accession":"0000899243-18-024819","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-024819","line_url":"/filing/0000899243-18-024819#line-2","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001643756","owner_name":"Aunins John G.","owner_display_name":"Aunins John G.","owner_url":"/insider/0001643756","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14279.0,"shares_display":"14,279","price_per_share":7.5684,"price_display":"7.57","price_state":"stated","total_value":108069.1836,"total_display":"108,069.18","total_whole":"108,069","shares_owned_after":132369.0,"shares_owned_after_display":"132,369","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-15","filed_date":"2018-09-19","scope":"insider"},{"id":6569044,"accession":"0000899243-18-020074","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-020074","line_url":"/filing/0000899243-18-020074#line-1","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001643756","owner_name":"Aunins John G.","owner_display_name":"Aunins John G.","owner_url":"/insider/0001643756","role":"Officer (Chief Technology Officer & EVP)","role_mark":"O","role_mark_label":"Officer (Chief Technology Officer & EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer & EVP","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14279.0,"shares_display":"14,279","price_per_share":8.1046,"price_display":"8.10","price_state":"stated","total_value":115725.5834,"total_display":"115,725.58","total_whole":"115,726","shares_owned_after":160927.0,"shares_owned_after_display":"160,927","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-15","filed_date":"2018-07-18","scope":"insider"},{"id":5978119,"accession":"0000899243-18-017017","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-017017","line_url":"/filing/0000899243-18-017017#line-1","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001643756","owner_name":"Aunins John G.","owner_display_name":"Aunins John G.","owner_url":"/insider/0001643756","role":"Officer (Chief Technology Officer & EVP)","role_mark":"O","role_mark_label":"Officer (Chief Technology Officer & EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer & EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14279.0,"shares_display":"14,279","price_per_share":8.5668,"price_display":"8.57","price_state":"stated","total_value":122325.3372,"total_display":"122,325.34","total_whole":"122,325","shares_owned_after":170206.0,"shares_owned_after_display":"170,206","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-15","filed_date":"2018-06-18","scope":"insider"},{"id":6849661,"accession":"0000899243-18-024819","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-024819","line_url":"/filing/0000899243-18-024819#line-1","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001643756","owner_name":"Aunins John G.","owner_display_name":"Aunins John G.","owner_url":"/insider/0001643756","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14279.0,"shares_display":"14,279","price_per_share":8.0818,"price_display":"8.08","price_state":"stated","total_value":115400.0222,"total_display":"115,400.02","total_whole":"115,400","shares_owned_after":146648.0,"shares_owned_after_display":"146,648","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-15","filed_date":"2018-09-19","scope":"insider"},{"id":6113366,"accession":"0000899243-18-010837","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-010837","line_url":"/filing/0000899243-18-010837#line-1","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001643756","owner_name":"Aunins John G.","owner_display_name":"Aunins John G.","owner_url":"/insider/0001643756","role":"Officer (Chief Technology Officer & EVP)","role_mark":"O","role_mark_label":"Officer (Chief Technology Officer & EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer & EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14279.0,"shares_display":"14,279","price_per_share":7.5822,"price_display":"7.58","price_state":"stated","total_value":108266.2338,"total_display":"108,266.23","total_whole":"108,266","shares_owned_after":184485.0,"shares_owned_after_display":"184,485","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-25","filed_date":"2018-04-26","scope":"insider"},{"id":6309827,"accession":"0000899243-18-002334","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-002334","line_url":"/filing/0000899243-18-002334#line-2","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001643756","owner_name":"Aunins John G.","owner_display_name":"Aunins John G.","owner_url":"/insider/0001643756","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1738.0,"shares_display":"1,738","price_per_share":11.02,"price_display":"11.02","price_state":"stated","total_value":19152.76,"total_display":"19,152.76","total_whole":"19,153","shares_owned_after":198764.0,"shares_owned_after_display":"198,764","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-26","filed_date":"2018-01-30","scope":"insider"},{"id":9204552,"accession":"0000899243-18-002323","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-002323","line_url":"/filing/0000899243-18-002323#line-1","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001643756","owner_name":"Aunins John G.","owner_display_name":"Aunins John G.","owner_url":"/insider/0001643756","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1623.0,"shares_display":"1,623","price_per_share":10.14,"price_display":"10.14","price_state":"stated","total_value":16457.22,"total_display":"16,457.22","total_whole":"16,457","shares_owned_after":195502.0,"shares_owned_after_display":"195,502","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-19","filed_date":"2018-01-30","scope":"insider"},{"id":4069489,"accession":"0000899243-17-029325","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-029325","line_url":"/filing/0000899243-17-029325#line-2","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001643756","owner_name":"Aunins John G.","owner_display_name":"Aunins John G.","owner_url":"/insider/0001643756","role":"Officer (Chief Technology Officer & EVP)","role_mark":"O","role_mark_label":"Officer (Chief Technology Officer & EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer & EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1623.0,"shares_display":"1,623","price_per_share":10.14,"price_display":"10.14","price_state":"stated","total_value":16457.22,"total_display":"16,457.22","total_whole":"16,457","shares_owned_after":59437.0,"shares_owned_after_display":"59,437","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-19","filed_date":"2017-12-20","scope":"insider"},{"id":2235274,"accession":"0000899243-16-028243","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-16-028243","line_url":"/filing/0000899243-16-028243#line-1","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001643756","owner_name":"Aunins John G.","owner_display_name":"Aunins John G.","owner_url":"/insider/0001643756","role":"Officer (Chief Technology Officer & EVP)","role_mark":"O","role_mark_label":"Officer (Chief Technology Officer & EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer & EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9390.0,"shares_display":"9,390","price_per_share":10.87,"price_display":"10.87","price_state":"stated","total_value":102069.3,"total_display":"102,069.30","total_whole":"102,069","shares_owned_after":192125.0,"shares_owned_after_display":"192,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-29","filed_date":"2016-08-30","scope":"insider"},{"id":3240503,"accession":"0000899243-16-025947","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-16-025947","line_url":"/filing/0000899243-16-025947#line-1","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001643756","owner_name":"Aunins John G.","owner_display_name":"Aunins John G.","owner_url":"/insider/0001643756","role":"Officer (Chief Technology Officer & EVP)","role_mark":"O","role_mark_label":"Officer (Chief Technology Officer & EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer & EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9250.0,"shares_display":"9,250","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":323750.0,"total_display":"323,750.00","total_whole":"323,750","shares_owned_after":201515.0,"shares_owned_after_display":"201,515","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-27","filed_date":"2016-07-29","scope":"insider"},{"id":2501383,"accession":"0000899243-16-025730","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-16-025730","line_url":"/filing/0000899243-16-025730#line-2","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001643756","owner_name":"Aunins John G.","owner_display_name":"Aunins John G.","owner_url":"/insider/0001643756","role":"Officer (Chief Technology Officer & EVP)","role_mark":"O","role_mark_label":"Officer (Chief Technology Officer & EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer & EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9390.0,"shares_display":"9,390","price_per_share":34.18,"price_display":"34.18","price_state":"stated","total_value":320950.2,"total_display":"320,950.20","total_whole":"320,950","shares_owned_after":210765.0,"shares_owned_after_display":"210,765","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-25","filed_date":"2016-07-26","scope":"insider"},{"id":2712739,"accession":"0000899243-16-023886","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-16-023886","line_url":"/filing/0000899243-16-023886#line-1","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001643756","owner_name":"Aunins John G.","owner_display_name":"Aunins John G.","owner_url":"/insider/0001643756","role":"Officer (Chief Technology Officer & EVP)","role_mark":"O","role_mark_label":"Officer (Chief Technology Officer & EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer & EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9390.0,"shares_display":"9,390","price_per_share":27.23,"price_display":"27.23","price_state":"stated","total_value":255689.7,"total_display":"255,689.70","total_whole":"255,690","shares_owned_after":32655.0,"shares_owned_after_display":"32,655","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-27","filed_date":"2016-06-29","scope":"insider"},{"id":2048673,"accession":"0000899243-16-021559","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-16-021559","line_url":"/filing/0000899243-16-021559","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001643756","owner_name":"Aunins John G.","owner_display_name":"Aunins John G.","owner_url":"/insider/0001643756","role":"Officer (Chief Technology Officer & EVP)","role_mark":"O","role_mark_label":"Officer (Chief Technology Officer & EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer & EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14015.0,"shares_display":"14,015","price_per_share":30.04550838387442,"price_display":"30.05","price_state":"stated","total_value":421087.8,"total_display":"421,087.80","total_whole":"421,088","shares_owned_after":42695.0,"shares_owned_after_display":"42,695","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-31","filed_date":"2016-06-02","scope":"insider","n_lines":2},{"id":9204439,"accession":"0000899243-16-028321","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-16-028321","line_url":"/filing/0000899243-16-028321#line-1","is_derivative":false,"issuer_cik":"0001643756","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001643756","owner_cik":"0001643756","owner_name":"Aunins John G.","owner_display_name":"Aunins John G.","owner_url":"/insider/0001643756","role":"Officer (Chief Technology Officer & EVP)","role_mark":"O","role_mark_label":"Officer (Chief Technology Officer & EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer & EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18640.0,"shares_display":"18,640","price_per_share":31.94,"price_display":"31.94","price_state":"stated","total_value":595361.6,"total_display":"595,361.60","total_whole":"595,362","shares_owned_after":56060.0,"shares_owned_after_display":"56,060","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-25","filed_date":"2016-08-31","scope":"insider"},{"id":2579284,"accession":"0000899243-16-018635","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-16-018635","line_url":"/filing/0000899243-16-018635#line-1","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001643756","owner_name":"Aunins John G.","owner_display_name":"Aunins John G.","owner_url":"/insider/0001643756","role":"Officer (Chief Technology Officer & EVP)","role_mark":"O","role_mark_label":"Officer (Chief Technology Officer & EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer & EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18640.0,"shares_display":"18,640","price_per_share":31.94,"price_display":"31.94","price_state":"stated","total_value":595361.6,"total_display":"595,361.60","total_whole":"595,362","shares_owned_after":56060.0,"shares_owned_after_display":"56,060","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-25","filed_date":"2016-04-27","scope":"insider"},{"id":2048400,"accession":"0000899243-16-016852","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-16-016852","line_url":"/filing/0000899243-16-016852#line-1","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001643756","owner_name":"Aunins John G.","owner_display_name":"Aunins John G.","owner_url":"/insider/0001643756","role":"Officer (Chief Technology Officer & EVP)","role_mark":"O","role_mark_label":"Officer (Chief Technology Officer & EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer & EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9390.0,"shares_display":"9,390","price_per_share":23.89,"price_display":"23.89","price_state":"stated","total_value":224327.1,"total_display":"224,327.10","total_whole":"224,327","shares_owned_after":74700.0,"shares_owned_after_display":"74,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-28","filed_date":"2016-03-29","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":21,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":21,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":21},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001609809","name":"Seres Therapeutics, Inc.","url":"/issuer/0001609809","role":"Officer (Chief Technology Officer & EVP)","n_filings":18,"first_seen":"2016-03-29","last_seen":"2018-12-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001643756","retrieved_at":"2026-08-22T05:46:21+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}